An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi). (Q38255343)

1 September 2017

1 reference

title

An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi). (English)

1 reference

1 September 2017

1 reference

Chiara Noli

1

1 reference

PubMed ID

25266647

1 September 2017

Manolis N Saridomichelakis

series ordinal

2

1 reference

PubMed ID

25266647

1 September 2017

language of work or name

1 reference

10 September 2014

1 reference

1 September 2017

The Veterinary Journal

1 reference

1 September 2017

202

1 reference

1 September 2017

3

1 reference

1 September 2017

425-435

1 reference

Leishmanicidal activity in vitro of Musa paradisiaca L. and Spondias mombin L. fractions.

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Asymptomatic colitis in naturally infected dogs with Leishmania infantum: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Clinical and radiographic study of bone and joint lesions in 26 dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Evaluation of the performance of selected in-house and commercially available PCR and real-time PCR assays for the detection of Leishmania DNA in canine clinical samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Comparison of two commercial rapid in-clinic serological tests for detection of antibodies against Leishmania spp. in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Chemotherapy of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Detection of Leishmania infantum kinetoplast minicircle DNA by Real Time PCR in hair of dogs with leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Atypical forms of canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Paraparesis caused by vertebral canal leishmaniotic granuloma in a dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Haemostatic disorders in dogs naturally infected by Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Glomerular filtration rate in dogs with leishmaniasis and chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Detection of Leishmania (L.) chagasi in canine skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Organic diseases mimicking acral lick dermatitis in six dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Diagnostic value of conjunctival swab sampling associated with nested PCR for different categories of dogs naturally exposed to Leishmania infantum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Infectious diseases. Has leishmaniasis become endemic in the U.S.?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Identification of Leishmania donovani amastigotes in canine tissues by immunoperoxidase staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Prognostic analytes in dogs with Leishmania infantum infection living in a non-endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Allopurinol therapy in imported dogs with leishmaniasis treated outside the endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Alkylphosphocholines: a new class of membrane-active anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Presumed brain infarctions in two dogs with systemic leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Intramedullary spinal cord mass presumptively associated with leishmaniasis in a dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective study of 158 cases (1989-1996)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine visceral leishmaniasis: performance of a rapid diagnostic test (Kalazar Detect) in dogs with and without signs of the disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Methods for diagnosis of canine leishmaniasis and immune response to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Efficacy of the liposome trifluralin in the treatment of experimental canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine leishmaniasis: the key points for qPCR result interpretation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Serum concentrations of acute phase proteins in dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Guidelines for treatment of leishmaniasis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Rapid immunochromatographic test for serodiagnosis of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Guidelines for diagnosis and clinical classification of leishmaniasis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Clinical and laboratory monitoring of dogs naturally infected by Leishmania infantum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Histopathological features of ocular leishmaniosis in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Factors associated with the occurrence of epistaxis in natural canine leishmaniasis (Leishmania infantum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Nodular lesions of the tongue in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Effects of allopurinol treatment on the progression of chronic nephritis in Canine leishmaniosis (Leishmania infantum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): a clinicopathological study of 26 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Performance of commercially available serological diagnostic tests to detect Leishmania infantum infection on experimentally infected dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

In vitro effect of Aloe vera, Coriandrum sativum and Ricinus communis fractions on Leishmania infantum and on murine monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Detection of Leishmania infection in paraffin-embedded skin biopsies of dogs using polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Prognosis and monitoring of leishmaniasis in dogs: a working group report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

A single-centre, open-label, controlled, randomized clinical trial to assess the preventive efficacy of a domperidone-based treatment programme against clinical canine leishmaniasis in a high prevalence area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Cutaneous involvement in canine leishmaniosis due to Leishmania infantum (syn. L. chagasi).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Regional parasite density in the skin of dogs with symptomatic canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Update on molecular techniques for diagnostic testing of infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Serum cardiac troponin I concentrations in dogs with leishmaniasis: correlation with age and clinicopathologic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Iron status and C-reactive protein in canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Evaluation of the efficacy of two leishmanins in asymptomatic dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

LeishVet guidelines for the practical management of canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Qualitative and quantitative polymerase chain reaction (PCR) for detection of Leishmania in spleen samples from naturally infected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Treatment of Bolivian mucosal leishmaniasis with miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Trial of oral miltefosine for visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Myocarditis and generalised vasculitis associated with leishmaniosis in a dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Masticatory and skeletal muscle myositis in canine leishmaniasis (Leishmania infantum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Possible mechanism of miltefosine-mediated death of Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Meningeal leishmaniosis induced by Leishmania infantum in naturally infected dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

Antigenic components of partially purified antigens of Leishmania donovani infantum recognized by sera from dogs with asymptomatic or active visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2014.09.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TVJL.2014.09.002

1 reference

1 September 2017

1 reference

PubMed ID

25266647